NYSE · CON
Healthcare · Medical - Equipment & Services
$35.01
Up+$0.39 (+1.13%)
Updated Sep 26, 2026, 5:03 PM
SID Score
7.6/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
CON closed at $35.01 after 20 trading sessions, up 2.19% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 25, 2026 | $34.32 | $35.07 | $34.32 | $35.01 | 571.37K |
| Sep 24, 2026 | $34.61 | $35.1997 | $34.41 | $34.62 | 841.39K |
| Sep 23, 2026 | $34.85 | $35.22 | $34.545 | $34.79 | 815.43K |
| Sep 22, 2026 | $34.48 | $35.44 | $34.48 | $34.88 | 681.27K |
| Sep 21, 2026 | $35.31 | $35.51 | $34.5883 | $34.77 | 743.22K |
| Sep 18, 2026 | $35.56 | $35.66 | $34.78 | $35.47 | 4.87M |
| Sep 17, 2026 | $36.50 | $36.6615 | $35.49 | $35.53 | 1.12M |
| Sep 16, 2026 | $35.15 | $36.71 | $35.14 | $36.37 | 1.09M |
| Sep 15, 2026 | $35.71 | $35.95 | $35.45 | $35.62 | 830.03K |
| Sep 14, 2026 | $34.56 | $36.05 | $34.52 | $35.81 | 1.09M |
| Sep 11, 2026 | $34.61 | $34.98 | $34.5467 | $34.95 | 655.27K |
| Sep 10, 2026 | $34.67 | $34.9399 | $34.16 | $34.24 | 612.07K |
| Sep 9, 2026 | $33.75 | $34.31 | $33.32 | $34.18 | 649.71K |
| Sep 8, 2026 | $33.99 | $34.42 | $33.59 | $33.88 | 724.03K |
| Sep 4, 2026 | $34.24 | $34.75 | $34.225 | $34.47 | 363.45K |
| Sep 3, 2026 | $34.30 | $34.60 | $33.753 | $34.51 | 841.96K |
| Sep 2, 2026 | $34.07 | $34.60 | $34.00 | $34.03 | 658.44K |
| Sep 1, 2026 | $33.98 | $34.34 | $33.805 | $33.89 | 587.2K |
| Aug 31, 2026 | $34.33 | $34.33 | $33.62 | $33.74 | 838.95K |
| Aug 28, 2026 | $34.92 | $34.92 | $34.192 | $34.26 | 508.13K |
The latest Smart Investors Daily articles mentioning CON.
CON research
Company profile and research snapshot.
Concentra Group Holdings Parent Inc is a provider of occupational health services in the United States. The business is organized into three operating segments: occupational health centers, onsite health clinics, and other businesses.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 10, 2026 | JP Morgan | Overweight | — |
| Aug 11, 2026 | Wells Fargo | Overweight | — |
| Aug 10, 2026 | RBC Capital | Outperform | — |
| Aug 10, 2026 | Truist Securities | Buy | — |
| Jul 14, 2026 | Truist Securities | Buy | — |
No generated briefing is available yet.
Benzinga · Mar 5, 2026
Wells Fargo analyst Stephen Baxter maintains Concentra Group Holdings (NYSE:CON) with a Overweight and raises the price target from $25 to $28.
SeekingAlpha · Feb 27, 2026
SeekingAlpha · Feb 27, 2026
ChartMill · Feb 26, 2026
Concentra (CON) beats Q4 earnings and revenue estimates with strong patient volume and strategic clinic expansion, while issuing confident 2026 guidance.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning CON.
